Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia
Clinical trial NCT02241031 · UNKNOWN
Trial details
- NCT number
- NCT02241031
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-09-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.